Injectable Drug Delivery Market to be at Forefront by 2019

Injectable drug delivery is defined as introduction of a drug or drugs in the patient by using a delivery device. Injectables allow the transport of drugs formulated in liquid form, directly in the body. Even though, they may be designed to transport the drug to specific part of the body.

Report Overview @ https://www.transparencymarketresearch.com/injectable-drug-delivery-market.html

Such drug delivery technology by the use of injections is majorly segmented into devices and formulations, and is commonly categorized as follows:

Type of formulation: microspheres, liposomes, nanoparticles

Type of device: needle free injectors, auto injectors, disposable syringes, reusable needles, pre-filled syringes, pen needle

Type of delivery method: intravenous, intramuscular, intraperitoneal, subcutaneous

Therapeutic applications: orphan diseases, auto-immune disease, oncology and others

Some of the major factors driving the growth of injectables are increase in the number of cancer and diabetic patients globally, improved patient compliance to drug delivery system and technology advancement. Out of the all the segments of this market, the formulation technologies market occupies the major share globally due to rapid development of nanotechnologies. The key deterrents restraining the growth of global injectables market include patient safety issues, injuries caused while administering injectables, development of alternate drug delivery methods and product recalls.

Download Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1336

The global injectable drug delivery market is dominated by North America and is followed by Europe. However the North American region lags behind European injectable market in self-injection devices due to low penetration rate of pen injectors in the U.S. The emerging Asian and Latin American countries collectively represent the fastest growing market for injectables due to the increase in incidences of cancer and diabetes in patients and also their compliance to novel technologies. Furthermore, the drug and device manufacturers are focusing on major emerging injectables market of Asia and Latin America due to less stringent regulations for acquiring approvals on devices and less competition.

Pre-Book Full Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=1336

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com

This release was published on openPR.